查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786335

全球COVID-19藥物輸送裝置市場

COVID-19 Drug Delivery Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 277 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年，全球 COVID-19 藥物輸送設備市場規模將達到 16 億美元

全球COVID-19藥物輸送設備市場規模在2024年估計為16億美元，預計到2030年將達到16億美元，在2024-2030年的分析期內，複合年成長率為-0.1%。預填充式注射器是本報告分析的細分市場之一，預計其複合年成長率為0.0%，到分析期結束時規模將達到7.906億美元。無針注射器細分市場在分析期間的複合年成長率估計為-0.3%。

美國市場規模估計為 4.458 億美元，中國市場預計複合年成長率為 0.1%

美國新冠藥物輸送設備市場規模預計2024年達到4.458億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到2.768億美元，在2024-2030年的分析期內，複合年成長率為0.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為-0.2%和-0.1%。在歐洲，預計德國市場的複合年成長率約為-0.2%。

全球 COVID-19 藥物輸送設備市場 - 主要趨勢與促進因素摘要

疫情如何改變藥物輸送：了解醫療保健重點的轉變

COVID-19 大流行重塑了全球醫療保健產業，加速了對先進藥物輸送設備的需求，以確保有效且安全地使用抗病毒治療劑和疫苗。 COVID-19 疫苗的快速研發和交付需要擴大注射器和自動注射器的生產，導致藥物輸送設備市場空前成長。此外，住院 COVID-19 患者激增，需要改善吸入和霧化療法來治療呼吸道併發症。這場大流行也凸顯了自我給藥解決方案的重要性，促使人們轉向預填充式注射器、自動注射器和穿戴式藥物輸送系統。遠端醫療整合和家庭醫療保健解決方案進一步刺激了對能夠進行遠端監控和劑量追蹤的智慧型藥物傳輸設備的需求。此外，對全球疫情防範的日益重視促使政府和製藥公司投資擴充性且高效的藥物輸送基礎設施。

哪些藥物輸送設備需求最大？探索關鍵產品細分市場

COVID-19 藥物輸送設備市場由多個部分組成，包括注射器、吸入器、自動注射器、輸液幫浦和經皮貼片。預填充式注射器是疫苗接種中最關鍵的組件之一，製造商正在擴大產量以滿足全球需求。霧化器和乾粉吸入器等吸入式藥物輸送系統在管理 COVID-19 相關呼吸道併發症發揮關鍵作用，尤其是在高風險患者中。隨著患者尋求非接觸式、自我給藥的治療方案，胰島素幫浦和智慧注射器等穿戴式藥物傳輸設備越來越受歡迎。此外，用於疫苗輸送的微針貼片的出現為傳統注射提供了一種新的替代方案，減少了對低溫運輸儲存的需求並提高了偏遠地區的可及性。對針刺傷和患者依從性的擔憂也在加速到無針藥物輸送系統的轉變。

創新如何徹底改變 COVID-19 藥物傳輸：人工智慧、奈米技術和智慧設備的作用

這次大流行刺激了藥物輸送設備的技術創新，從而開發出更有效率、更患者友善的解決方案。具有即時症狀追蹤功能的主導吸入器提高了呼吸系統治療的依從性，特別是對於長期 COVID-19併發症。奈米技術在藥物傳輸中的應用提高了 COVID-19 治療的生物生物有效性和靶向作用，最大限度地減少了副作用並最佳化了治療效果。此外，具有遠端連接功能的智慧型藥物傳輸設備可實現遠端患者監控，減少就診次數並改善醫療服務。溫度穩定的疫苗製劑的開發，結合無針輸送系統，正在解決與大規模疫苗宣傳活動相關的後勤挑戰。此外，生物製藥的進步促成了長效抗病毒製劑的開發，減少了給藥頻率並提高了治療效果。

推動COVID-19藥物輸送設備市場成長的因素有哪些？關鍵市場影響因素說明

COVID-19 藥物輸送設備市場的成長受到多種因素的推動，包括全球疫苗接種率的提高、藥物輸送技術的進步以及自我給藥治療方案的擴展。對生物製藥的投資不斷增加，加速了下一代藥物輸送解決方案的開發，提高了患者的依從性和治療效果。電子商務和數位醫療平台的擴張也推動了自我給藥設備的採用。此外，政府旨在防範疫情的措施正在增加可擴展疫苗分發和緊急醫療供應鏈的資金投入。向個人化醫療和標靶藥物輸送方法的轉變正在進一步加強市場成長。隨著醫療產業在後疫情時代繼續發展，創新、數位整合和全球醫療基礎設施的加強預計將推動 COVID-19 藥物輸送設備市場的擴張。

部分

產品（預填充式注射器、無針注射器、吸入器、貼劑）、給藥途徑（腸外、鼻內、其他）、通路（醫院藥局、零售藥局、網路藥局）

受訪公司範例

  • ApiJect Systems Corp.
  • AstraZeneca plc
  • Becton, Dickinson and Company（BD）
  • Bharat Biotech
  • CanSino Biologics Inc.
  • Cardinal Health
  • Croda International Plc
  • Gerresheimer AG
  • GlaxoSmithKline plc（GSK）
  • Hindustan Syringes & Medical Devices Ltd.
  • Inovio Pharmaceuticals
  • Johnson & Johnson
  • Moderna, Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • SCHOTT AG
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Terumo Corporation

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP30276

Global COVID-19 Drug Delivery Devices Market to Reach US$1.6 Billion by 2030

The global market for COVID-19 Drug Delivery Devices estimated at US$1.6 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of -0.1% over the analysis period 2024-2030. Prefilled Syringe, one of the segments analyzed in the report, is expected to record a 0.0% CAGR and reach US$790.6 Million by the end of the analysis period. Growth in the Needle-free Injectors segment is estimated at -0.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$445.8 Million While China is Forecast to Grow at 0.1% CAGR

The COVID-19 Drug Delivery Devices market in the U.S. is estimated at US$445.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$276.8 Million by the year 2030 trailing a CAGR of 0.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of -0.2% and -0.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately -0.2% CAGR.

Global COVID-19 Drug Delivery Devices Market - Key Trends & Drivers Summarized

How Has the Pandemic Transformed Drug Delivery? Understanding the Shift in Healthcare Priorities

The COVID-19 pandemic has reshaped the global healthcare industry, accelerating the demand for advanced drug delivery devices to ensure efficient and safe administration of antiviral treatments and vaccines. The rapid development and distribution of COVID-19 vaccines necessitated the expansion of syringe and auto-injector manufacturing, leading to unprecedented growth in the drug delivery devices market. Additionally, the surge in hospitalized COVID-19 patients required improved inhalation and nebulization therapies for managing respiratory complications. The pandemic also underscored the importance of self-administered drug delivery solutions, prompting a shift toward prefilled syringes, autoinjectors, and wearable drug delivery systems. Telemedicine integration and at-home healthcare solutions have further increased demand for smart drug delivery devices that enable remote monitoring and dosage tracking. Additionally, the rising emphasis on global pandemic preparedness has prompted governments and pharmaceutical companies to invest in scalable and efficient drug delivery infrastructure.

Which Drug Delivery Devices Have Seen the Highest Demand? Exploring Key Product Segments

The COVID-19 drug delivery devices market comprises various segments, including syringes, inhalers, autoinjectors, infusion pumps, and transdermal patches. Prefilled syringes have been one of the most critical components in vaccine administration, with manufacturers ramping up production to meet global demand. Inhalation drug delivery systems, including nebulizers and dry powder inhalers, have played a crucial role in managing COVID-19-related respiratory complications, particularly among high-risk patients. Wearable drug delivery devices, such as insulin pumps and smart injectors, have gained traction as patients seek contactless and self-administered treatment solutions. Additionally, the emergence of microneedle patches for vaccine delivery has introduced a novel alternative to traditional injections, reducing the need for cold-chain storage and improving accessibility in remote regions. The shift toward needle-free drug delivery systems has also accelerated, driven by concerns over needle-stick injuries and patient compliance.

How Is Innovation Revolutionizing COVID-19 Drug Delivery? The Role of AI, Nanotechnology & Smart Devices

The pandemic has driven a wave of technological innovations in drug delivery devices, leading to the development of more efficient, patient-friendly solutions. AI-driven inhalers equipped with real-time symptom tracking have enhanced respiratory treatment adherence, particularly for long-term COVID-19 complications. The integration of nanotechnology in drug delivery has improved the bioavailability and targeted action of COVID-19 therapeutics, minimizing side effects and optimizing treatment outcomes. Additionally, smart drug delivery devices with remote connectivity features have facilitated remote patient monitoring, reducing hospital visits and improving healthcare accessibility. The development of temperature-stable vaccine formulations, combined with needle-free delivery systems, has addressed logistical challenges associated with mass immunization campaigns. Furthermore, advancements in biopharmaceuticals have led to the creation of long-acting antiviral formulations, reducing the frequency of drug administration and enhancing treatment efficacy.

What’s Driving the Growth of the COVID-19 Drug Delivery Devices Market? Key Market Influencers Explained

The growth in the COVID-19 drug delivery devices market is driven by several factors, including increased global immunization efforts, advancements in drug delivery technology, and the expansion of self-administered treatment options. The rising investment in biopharmaceuticals has accelerated the development of next-generation drug delivery solutions, improving patient compliance and therapeutic outcomes. The expansion of e-commerce and digital healthcare platforms has also facilitated the widespread availability of self-administration drug delivery devices. Additionally, government initiatives aimed at pandemic preparedness have led to increased funding for scalable vaccine distribution and emergency medical supply chains. The shift toward personalized medicine and targeted drug delivery approaches has further strengthened market growth. As the healthcare industry continues to evolve post-pandemic, the COVID-19 drug delivery devices market is expected to expand, driven by innovation, digital integration, and enhanced global healthcare infrastructure.

SCOPE OF STUDY:

The report analyzes the COVID-19 Drug Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Prefilled Syringe, Needle-free Injectors, Inhalers, Patches); Route of Administration (Parenteral Administration, Nasal Administration, Other Administrations); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • ApiJect Systems Corp.
  • AstraZeneca plc
  • Becton, Dickinson and Company (BD)
  • Bharat Biotech
  • CanSino Biologics Inc.
  • Cardinal Health
  • Croda International Plc
  • Gerresheimer AG
  • GlaxoSmithKline plc (GSK)
  • Hindustan Syringes & Medical Devices Ltd.
  • Inovio Pharmaceuticals
  • Johnson & Johnson
  • Moderna, Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi S.A.
  • SCHOTT AG
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • COVID-19 Drug Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Global Vaccine Distribution Drives Demand for Efficient COVID-19 Drug Delivery Devices
    • Growing Focus on Vaccine Equity and Accessibility Expands Addressable Market for Affordable Drug Delivery Solutions
    • Innovation in Needle-Free and Non-Invasive Drug Delivery Technologies Accelerates Adoption for COVID-19 Vaccines
    • Increasing Government Support and Funding for Vaccine Rollout Programs Propels Growth in Drug Delivery Device Development
    • Technological Advancements in Microneedle Patches Strengthen the Business Case for Non-Traditional Vaccine Delivery Methods
    • The Need for Mass Immunization Drives Adoption of Scalable, High-Efficiency Drug Delivery Devices
    • Rising Preference for Self-Administration and At-Home Vaccine Delivery Solutions Expands Market Opportunities
    • Expansion of Cold Chain Logistics and Temperature-Sensitive Packaging Solutions Supports Growth in Drug Delivery Devices
    • Heightened Focus on Global Pandemic Preparedness Stimulates Innovation in Rapid Response Drug Delivery Systems
    • Regulatory Approvals for Emergency Use Authorizations (EUAs) Accelerate the Development and Distribution of COVID-19 Drug Delivery Devices
    • Consumer Trust in New Vaccine Technologies Drives Demand for Safe, Reliable Drug Delivery Mechanisms
    • Global Push for Digital Health Solutions Expands Adoption of Connected Drug Delivery Devices with IoT Integration
    • Increasing Public-Private Partnerships for Vaccine Research and Development Expands Opportunities for Drug Delivery Device Manufacturers
    • Rise in Immunocompromised Populations and Increased Health Risks Post-Pandemic Sustains Demand for Effective Drug Delivery Systems
    • Growth in Collaborative Research Between Pharma Companies and Tech Firms Drives Innovation in Delivery Device Designs
    • Push for Streamlined Healthcare Supply Chains Strengthens Market Demand for Cost-Effective Drug Delivery Solutions
    • Emergence of New Variants of COVID-19 Drives Demand for Advanced, Flexible Drug Delivery Devices to Address Evolving Therapeutic Needs
    • Increased Investment in AI and Machine Learning for Personalized Vaccine Dosing Expands Market Potential for Smart Drug Delivery Systems
    • Rising Focus on Patient Comfort and Experience Spurs Growth in Painless and Low-Discomfort Delivery Devices
    • Evolving Regulatory Landscape and Compliance Challenges in Vaccine Delivery Highlight the Need for Robust, Adaptable Drug Delivery Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World COVID-19 Drug Delivery Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Prefilled Syringe by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Prefilled Syringe by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Needle-free Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Needle-free Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Nasal Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Nasal Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Other Administrations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • CANADA
    • TABLE 30: Canada Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • JAPAN
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 36: Japan Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • CHINA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 42: China Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • EUROPE
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 48: Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • FRANCE
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • GERMANY
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • UNITED KINGDOM
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 82: Spain Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Spain 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 84: Spain Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Spain 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 88: Russia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Russia 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 90: Russia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Russia 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 96: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of Europe 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • ASIA-PACIFIC
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 102: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • AUSTRALIA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 106: Australia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Australia 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 108: Australia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Australia 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • INDIA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 112: India Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: India 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 114: India Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: India 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • SOUTH KOREA
    • TABLE 118: South Korea Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: South Korea 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 120: South Korea Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: South Korea 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 126: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • LATIN AMERICA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 130: Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 131: Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030
    • TABLE 132: Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 136: Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • ARGENTINA
    • TABLE 138: Argentina Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Argentina 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 142: Argentina Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Argentina 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • BRAZIL
    • TABLE 144: Brazil Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Brazil 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 148: Brazil Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Brazil 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • MEXICO
    • TABLE 150: Mexico Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Mexico 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 154: Mexico Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 155: Mexico 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 156: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 157: Rest of Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 160: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 161: Rest of Latin America 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • MIDDLE EAST
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 162: Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 163: Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 166: Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 167: Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 168: Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 169: Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 172: Iran Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 173: Iran 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 174: Iran Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 175: Iran 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 178: Israel Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 179: Israel 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 180: Israel Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 181: Israel 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 185: Saudi Arabia 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 186: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 187: Saudi Arabia 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 190: UAE Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 191: UAE 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 192: UAE Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 193: UAE 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 197: Rest of Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 198: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 199: Rest of Middle East 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030
  • AFRICA
    • COVID-19 Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Product - Prefilled Syringe, Needle-free Injectors, Inhalers and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa 6-Year Perspective for COVID-19 Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled Syringe, Needle-free Injectors, Inhalers and Patches for the Years 2025 & 2030
    • TABLE 202: Africa Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Distribution Channel - Online Pharmacies, Hospital Pharmacies and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 203: Africa 6-Year Perspective for COVID-19 Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacies, Hospital Pharmacies and Retail Pharmacies for the Years 2025 & 2030
    • TABLE 204: Africa Recent Past, Current & Future Analysis for COVID-19 Drug Delivery Devices by Route Of Administration - Parenteral Administration, Nasal Administration and Other Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 205: Africa 6-Year Perspective for COVID-19 Drug Delivery Devices by Route Of Administration - Percentage Breakdown of Value Sales for Parenteral Administration, Nasal Administration and Other Administrations for the Years 2025 & 2030

IV. COMPETITION